🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well a dose adjusted regimen consisting of ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-01-14
Trial ID
NCT02199184
RATIONALE: Monoclonal antibodies, such as epratuzumab and rituximab, can bl...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2006-01
Trial ID
NCT00301821
Treatments Being Tested
This phase II trial is studying how well giving combination chemotherapy to...
Status
Completed
Location
SWOG
Start Date
2005-06
Trial ID
NCT00121199
The purpose of this study is to clarify the impact of rituximab on clinical...
Status
Completed
Location
Chonbuk National University Hospital
Start Date
2011-08
Trial ID
NCT01448096
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Withdrawn
Location
Hoag Memorial Hospital Presbyterian
Start Date
1998-06
Trial ID
NCT00004039
This is a randomised, double-blind, positive drug parallel controlled equiv...
Status
Completed
Location
The First Affiliated Hospital of College of Medicine, Zhejiang University
Start Date
2019-07-25
Trial ID
NCT04361279
This is a prospective, single-arm, multi-center, phase II clinical study to...
Status
Recruiting
Location
Department of Medical Oncology, Sun Yat-Sen University Cancer Center
Start Date
2024-05-23
Trial ID
NCT06569485
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells ...
Status
Active Not Recruiting
Location
University of Arizona Cancer Center - North Campus /ID# 227463
Start Date
2023-02-08
Trial ID
NCT05578976
Treatments Being Tested
This pilot phase I trial studies the side effects of pembrolizumab and comb...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-11-24
Trial ID
NCT02541565
This is an open-label, multicentre Phase Ib study to evaluate the safety an...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-04-10
Trial ID
NCT06251180
Treatments Being Tested